Erratum to Bone morphogenetic protein-5 and early endothelial outgrowth cells (eEOCs) in acute ischemic kidney injury (AKI) and 5/6-chronic kidney disease (American Journal of Physiology - Renal Physiology (2013), 305, (F314-F322), 10.1152/ajprenal.00677.2012);Bone morphogenetic protein-5 and early endothelial outgrowth cells (eEOCs) in acute ischemic kidney injury (AKI) and 5/6-chronic kidney disease

American Journal of Physiology - Renal Physiology

Volumn 305, Issue 3, 2013, Pages

  Patschan, Daniel ^a   Schwarze, Katrin ^a   Lange, Andrea ^a   Meise, Nyree ^a   Henze, Elvira ^a   Becker, Jan Ulrich ^b   Patschan, Susann ^a   Müller, Gerhard A ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Acute renal failure; BMP 5; EPC

Indexed keywords

BONE MORPHOGENETIC PROTEIN 5; SMOOTH MUSCLE ACTIN;

ACUTE KIDNEY FAILURE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL SURVIVAL; CELL THERAPY; CELLULAR SECRETION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; EARLY ENDOTHELIAL OUTGROWTH CELL; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; FIBROSING ALVEOLITIS; KIDNEY FIBROSIS; KIDNEY FUNCTION; MALE; MOUSE; NEPHRECTOMY; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEINURIA; REPERFUSION INJURY; UNINEPHRECTOMY;

EID: 84880994950     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.zh2-7156-corr.2013     Document Type: Erratum

References (38)

1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967, 1997.
2. Boon MR, van der Horst G, van der Pluijm G, Tamsma JT, Smit JW, Rensen PC. Bone morphogenetic protein 7: a broad-spectrum growth factor with multiple target therapeutic potency. Cytokine Growth Factor Rev 22: 221-229, 2011.
3. Bramlage CP, Haupl T, Kaps C, Ungethum U, Krenn V, Pruss A, Muller GA, Strutz F, Burmester GR. Decrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther 8: R58, 2006.
4. Bramlage CP, Muller GA, Tampe B, Bevanda J, Maatouk I, Koziolek M, Lange K, Ahrens K, Schmid H, Cohen CD, Bramlage P, Kretzler M, Strutz F. The role of bone morphogenetic protein-5 (BMP-5) in human nephrosclerosis. J Nephrol 24: 647-655, 2011.
5. Burger D, Gutsol A, Carter A, Allan DS, Touyz RM, Burns KD. Human cord blood CD133 cells exacerbate ischemic acute kidney injury in mice. Nephrol Dial Transplant 27: 3781 3789, 2012.
6. Case J, Mead LE, Bessler WK, Prater D, White HA, Saadatzadeh MR, Bhavsar JR, Yoder MC, Haneline LS, Ingram DA. Human CD34 AC133 VEGFR-2 cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 35: 1109-1118, 2007.
7. Chade AR, Zhu X, Lavi R, Krier JD, Pislaru S, Simari RD, Napoli C, Lerman A, Lerman LO. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation 119: 547-557, 2009.
8. Chade AR, Zhu XY, Krier JD, Jordan KL, Textor SC, Grande JP, Lerman A, Lerman LO. Endothelial progenitor cells homing and renal repair in experimental renovascular disease. Stem Cells 28: 1039-1047, 2010.
9. Chen J, Li H, Addabbo F, Zhang F, Pelger E, Patschan D, Park HC, Kuo MC, Ni J, Gobe G, Chander PN, Nasjletti A, Goligorsky MS. Adoptive transfer of syngeneic bone marrow-derived cells in mice with obesity-induced diabetes: selenoorganic antioxidant ebselen restores stem cell competence. Am J Pathol 174: 701-711, 2009.
10. Fang Y, Tian X, Bai S, Fan J, Hou W, Tong H, Li D. Autologous transplantation of adipose-derived mesenchymal stem cells ameliorates streptozotocin-induced diabetic nephropathy in rats by inhibiting oxidative stress, pro-inflammatory cytokines and the p38 MAPK signaling pathway. Int J Mol Med 30: 85-92, 2012.
11. Garrison KR, Shemilt I, Donell S, Ryder JJ, Mugford M, Harvey I, Song F, Alt V. Bone morphogenetic protein (BMP) for fracture healing in adults. Cochrane Database Syst Rev CD006950, 2010.
12. Hendarto H, Inoguchi T, Maeda Y, Ikeda N, Zheng J, Takei R, Yokomizo H, Hirata E, Sonoda N, Takayanagi R. GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases. Metabolism 61: 1422-1434, 2012.
13. Kim M, Choe S. BMPs and their clinical potentials. BMB Rep 44: 619-634, 2011.
14. Liberman M, Johnson RC, Handy DE, Loscalzo J, Leopold JA. Bone morphogenetic protein-2 activates NADPH oxidase to increase endoplasmic reticulum stress and human coronary artery smooth muscle cell calcification. Biochem Biophys Res Commun 413: 436-441, 2011.
15. Lissenberg-Thunnissen SN, de Gorter DJ, Sier CF, Schipper IB. Use and efficacy of bone morphogenetic proteins in fracture healing. Int Orthop 35: 1271-1280, 2011.
16. Ma YY, Sun D, Li J, Yin ZC. Transplantation of endothelial progenitor cells alleviates renal interstitial fibrosis in a mouse model of unilateral ureteral obstruction. Life Sci 86: 798-807, 2010.
17. Mias C, Trouche E, Seguelas MH, Calcagno F, Dignat-George F, Sabatier F, Piercecchi-Marti MD, Daniel L, Bianchi P, Calise D, Bourin P, Parini A, Cussac D. Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Stem Cells 26: 1749-1757, 2008.
18. Morrell NW. Role of bone morphogenetic protein receptors in the development of pulmonary arterial hypertension. Adv Exp Med Biol 661: 251-264, 2010.
19. Patschan D, Hildebrandt A, Rinneburger J, Wessels JT, Patschan SA, Becker JU, Henze E, Kruger A, Muller GA. The hormone melatonin stimulates renoprotective effects of early outgrowth endothelial progenitor cells in acute ischemic kidney injury. Am J Physiol Renal Physiol 302: F1305-F1312, 2012.
20. Patschan D, Krupincza K, Patschan S, Zhang Z, Hamby C, Goligorsky MS. Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia: modulation by ischemic preconditioning. Am J Physiol Renal Physiol 291: F176-F185, 2006.
21. Patschan D, Patschan S, Gobe GG, Chintala S, Goligorsky MS. Uric acid heralds ischemic tissue injury to mobilize endothelial progenitor cells. J Am Soc Nephrol 18: 1516-1524, 2007.
22. Patschan D, Patschan S, Muller GA. Endothelial progenitor cells in acute ischemic kidney injury: strategies for increasing the cells' renoprotective competence. Int J Nephrol 2011: 828369, 2011.
23. Patschan D, Patschan S, Wessels JT, Becker JU, David S, Henze E, Goligorsky MS, Müller GA. Epac-1 activator 8-O-cAMP augments renoprotective effects of syngeneic [corrected] murine EPCs in acute ischemic kidney injury. Am J Physiol Renal Physiol 298: F78-F85, 2010.
24. Patschan D, Plotkin M, Goligorsky MS. Therapeutic use of stem and endothelial progenitor cells in acute renal injury: ça ira. Curr Opin Pharmacol 6: 176-183, 2006.
25. Sage AP, Tintut Y, Demer LL. Regulatory mechanisms in vascular calcification. Nat Rev Cardiol 7: 528-536, 2010.
26. Sangidorj O, Yang SH, Jang HR, Lee JP, Cha RH, Kim SM, Lim CS, Kim YS. Bone marrow-derived endothelial progenitor cells confer renal protection in a murine chronic renal failure model. Am J Physiol Renal Physiol 299: F325-F335, 2010.
27. Schulz TJ, Tseng YH. Emerging role of bone morphogenetic proteins in adipogenesis and energy metabolism. Cytokine Growth Factor Rev 20: 523-531, 2009.
28. Shi H, Patschan D, Dietz GPH, Bähr M, Plotkin M, Goligorsky MS. Glial cell line-derived neurotrophic growth factor increases motility and survival of cultured mesenchymal stem cells and ameliorates acute kidney injury. Am J Physiol Renal Physiol 294: F229-F235, 2008.
29. Starman JS, Bosse MJ, Cates CA, Norton HJ. Recombinant human bone morphogenetic protein-2 use in the off-label treatment of nonunions and acute fractures: a retrospective review. J Trauma Acute Care Surg 72: 676-681, 2012.
30. Sugimoto H, Grahovac G, Zeisberg M, Kalluri R. Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors. Diabetes 56: 1825-1833, 2007.
31. Vukicevic S, Basic V, Rogic D, Basic N, Shih MS, Shepard A, Jin D, Dattatreyamurty B, Jones W, Dorai H, Ryan S, Griffiths D, Maliakal J, Jelic M, Pastorcic M, Stavljenic A, Sampath TK. Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. J Clin Invest 102: 202-214, 1998.
32. Yeh CH, Chang CK, Cheng KC, Li YX, Zhang YW, Cheng JT. Role of bone morphogenetic proteins-7 (BMP-7) in the renal improvement effect of DangGui (Angelica sinensis) in type-1 diabetic rats. Evid Based Complement Alternat Med 2011: 796723, 2011.
33. Yoder MC, Ingram DA. The definition of EPCs and other bone marrow cells contributing to neoangiogenesis and tumor growth: is there common ground for understanding the roles of numerous marrow-derived cells in the neoangiogenic process? Biochim Biophys Acta 1796: 50-54, 2009.
34. Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 19: 2282-2287, 2008.
35. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9: 964-968, 2003.
36. Zeisberg M, Kalluri R. Fibroblasts emerge via epithelial-mesenchymal transition in chronic kidney fibrosis. Front Biosci 13: 6991-6998, 2008.
37. Zeisberg M, Muller GA, Kalluri R. Are there endogenous molecules that protect kidneys from injury? The case for bone morphogenic protein-7 (BMP-7). Nephrol Dial Transplant 19: 759-761, 2004.
38. Zhang H, Wada J, Kanwar YS, Tsuchiyama Y, Hiragushi K, Hida K, Shikata K, Makino H. Screening for genes up-regulated in 5/6 nephrectomized mouse kidney. Kidney Int 56: 549-558, 1999.